Faculty Profile
Dr. Parker
Barbara A. Parker, M.D.
Professor of Clinical Medicine
Division of Hematology-Oncology
Medical Director, Oncology Services
Moores UCSD Cancer Center
Office Address:
Division of Hematology-Oncology
University of California, San Diego
Moores UCSD Cancer Center
3855 Health Sciences Drive, MC-0987
La Jolla, CA 92093
baparker@ucsd.edu
Office: (858) 822-6195
FAX: (858) 822-6196
Education and Training
| BA | University of North Carolina, Chapel Hill | 1974 |
| MD | Stanford University | 1981 |
| Intern/Resident | University of California, San Diego | 1981-1985 |
Fellowship Hematology-Oncology |
University of California, San Diego | 1985-1987 |
Research Interests
Dr. Parker studies novel therapies for breast cancer, the impact of diet on breast cancer prognosis, and alteration in sleep and cognition that occur in breast cancer patients undergoing chemotherapy. She collaborates in studies evaluating translocation events in breast cancer and biomarkers of cancer development.
Publications
Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GGGGGR, Dimsdale J, Cohen-Zion M, Fioretino L. Fatigue, sleep and circadian rhythms prior to chemotheraphy for breast cancer. Support Care cancer, 14:201-209, 2006. Epub 2005, Jul 12.
Pierce JP, Stefanik ML, Flatt SW, Natarajan L, Sterfeld B, Madlensky L, Al-Delaimy WK, Thomson C, Kealey S, Hajek R, Parker BA, Newman VA, Caan B, Rock CR. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. Jour of Clinical Oncology, 2007 June 10;25(17):2345-51.
Mortimer JE, Parker BA, Flatt SW, Gold E, Wasserman L, Natarajan L, Pierce F. For the Whel Study Group. Tamoxifen hot flashes and recurrence in breast cancer. In: Breast Cancer Research Treatment, 2008 April; 108(3):421-6. Epub 2007, May 31.
Pierce JP. Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, Rock CR, Kealey S, Al-Delaimy WK, Bardwell WA, Carlson RW, Emond JA, Faerber S., Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Madlensky L, Marshall J, Newman VA, Ritenbaugh C, Thomson CA, Wasserman L, Stefanick ML. The Women’s Healthy Eating and Living (WHEL) Randomized Trial: influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer. JAMA, 2007;298:289-298.
Pierce JP, Newman VA, Natarajan L, Flatt SW, Al-Delaimy WK, Caan BJ, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Kealey S, Madlensky L, Marshall J, Ritenbaugh C, Rock CL. Stefanick ML, Thomson C, Wasserman L, Parker BA. Telephone counseling helps maintain long-term adherence to a high-vegetable dietary pattern. Jour of Nutrition, 2007;137:2291-2296.
Mills PJ, Ancoli-Israel S, Parker BA, Natarajan L, Hong S, Jain S, Sadler GR, von Kanel R. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. Brain, Behavior, and Immunity, 2008; 22:98-104. Epub 2007 Aug 15.
Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR, Dimsdale JE, Rissling H, He F, Ancoli-Israel S. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psycho-Oncology. Epub 2008, Aug. 1.
Gold EB, Pierce JP, Natarajan L, Stefanick ML, Laughlin GA, Caan BJ, Flatt SW, Emond JA, Saquib N, Madlensky L, Kealey S, Wasserman L, Thomson CA, Rock CR, Parker BA, Karanja N, Jones V, Hajek RA, Pu M, Mortin JE. A high vegetable, fruit and fiber dietary pattern may influence breast cancer prognosis in women without hot flashes: a secondary analysis from the women’s healthy eating and living (WHEL) study. Jour of Clinical Oncology, 2008 (pending publication).
